Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pichler

Showing results (121-130 of 323) with videos related to

Pageof 33
Sort By:
Journal of Clinical Pathology|October 8, 2013
miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitorMartin Pichler, Elke Winter, Anna Lena Ress, et al.
Journal of Clinical Pathology|October 5, 2016
Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistrySarah Kammerer, Stephan Wenzel Jahn, Elke Winter, et al.
Anticancer Research|May 31, 2015
Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell CarcinomaGeorg C Hutterer, Daniel Krieger, Edvin Mrsic, et al.
Cells|February 11, 2023
The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung CancerJoerg Lindenmann, Melanie Fediuk, Nicole Fink-Neuboeck, et al.
British Journal of Cancer|December 2, 2016
Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinomaOrietta Dalpiaz, Theresa Luef, Maximilian Seles, et al.
American Journal of Clinical Pathology|January 21, 2012
Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinomaMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
Plos One|September 11, 2014
Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patientsJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
American Journal of Surgery|January 15, 2015
The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patientsJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
Cancer Genomics & Proteomics|April 24, 2023
Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy OutcomeJaroslav Juracek, Marie Madrzyk, Karolina Trachtova, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2015
The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapyEva-Maria Thurner, Sabine Krenn-Pilko, Uwe Langsenlehner, et al.
Pageof 33

Showing results (121-130 of 323) with videos related to

Sort By:
Pageof 33
Journal of Clinical Pathology|October 8, 2013
miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitorMartin Pichler, Elke Winter, Anna Lena Ress, et al.
Journal of Clinical Pathology|October 5, 2016
Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistrySarah Kammerer, Stephan Wenzel Jahn, Elke Winter, et al.
Anticancer Research|May 31, 2015
Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell CarcinomaGeorg C Hutterer, Daniel Krieger, Edvin Mrsic, et al.
Cells|February 11, 2023
The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung CancerJoerg Lindenmann, Melanie Fediuk, Nicole Fink-Neuboeck, et al.
British Journal of Cancer|December 2, 2016
Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinomaOrietta Dalpiaz, Theresa Luef, Maximilian Seles, et al.
American Journal of Clinical Pathology|January 21, 2012
Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinomaMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
Plos One|September 11, 2014
Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patientsJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
American Journal of Surgery|January 15, 2015
The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patientsJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
Cancer Genomics & Proteomics|April 24, 2023
Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy OutcomeJaroslav Juracek, Marie Madrzyk, Karolina Trachtova, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2015
The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapyEva-Maria Thurner, Sabine Krenn-Pilko, Uwe Langsenlehner, et al.
Pageof 33